Alternatives to Tamoxifen for Breast Cancer Discussion Nov. 6

October 15, 2003

"Despite the fact that tamoxifen has been in clinical use for 30 years, there are still concerns and questions about its use."

The Comprehensive Breast Cancer Program at the James P. Wilmot Cancer Center will present a discussion on alternatives to Tamoxifen at 5:30 p.m., Thursday, Nov. 6.  The dinner program will be in the University of Rochester Medical Center Conference Center’s William and Mildred Levine Pavilion, located at the corner of Elmwood Avenue and Kendrick Road.

Jennifer J. Griggs, M.D., M.P.H., medical director of the program, will offer information on recent research findings on chemoprevention drugs and techniques for women who are at risk of breast cancer or a recurrence. The program will allow time for participants to ask questions.

"Despite the fact that tamoxifen has been in clinical use for 30 years, there are still concerns and questions about its use. This program will address the latest research on alternatives to tamoxifen and will also address lifestyle changes that women can make to live the healthiest life after breast cancer.”

This is one in a series of quarterly education sessions for women who are undergoing treatment and survivors of the disease, their families and friends.

The cost is $20 per person, which includes dinner.  Scholarships are available.  To register, call Kristin Galvin-Burwick at (585) 275-4797 or e-mail kristin_galvinburwick@urmc.rochester.edu.

Questions about the Comprehensive Breast Cancer Program may be directed to Jennifer J. Griggs, M.D., M.P.H., medical director, or Beverly Brooks, associate director of community education, at (585) 275-4797.

##

For Media Inquiries:
Leslie White
(585) 273-1119
Email Leslie White